Roadmaps to the Intertwined IP and Regulatory Regimes in China

May 13, 2020 9:00 AM to 10:00 AM


Virtual - all times are eastern daylight time


60 Minutes of MCLE

Moderator: Jeremy K. McKown, Janssen R&D, New Brunswick, NJ


Developments in pharmaceutical IP and regulatory coordination efforts to stimulate faster and better pharmaceutical development in China
Juhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China 

Using Patent Law and Policy for Incentivizing Green Technology Innovation in China

Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China

Presented by the IP Practice in China Committee and the US Group of AIPPI


  • Luo Photo Luo, Juhua

    CCPIT Patent and Trademark Law Office

    Mr. Luo's practice focuses mainly on prosecution of patent.
  • McKown, Jeremy square200 McKown, Jeremy K.

    Janssen R&D at Johnson & Johnson | Vice President of Law

    Jeremy is a Vice-President at Janssen R&D, a Johnson & Johnson affiliate (J&J), where he manages a global team of attorneys and professionals focused on drafting and negotiating complex agreements related to J&J's pharmaceutical business.
  • Cao Photo Cao, Wen

    Shanghai Office of NTD | Senior Partner

    Ms. Cao serves as the principal of NTD Shanghai Office.